Oncotarget

Vol 9, No 65

August 21, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 65 of Oncotarget features Figure 5, "Waterfall plot showing response by % change in tumor size after Y-90 radioembolization," by Dendy, et al.

Table of Contents

News

Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs

Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs

https://doi.org/10.18632/oncotarget.25968

Ting-Hui Wu, Nagla Karim,  and Jeffrey A. Moscow
32404-32405
PDF  |  Order a Reprint

Editorial

Clinical utility of chromatin analysis

Clinical utility of chromatin analysis

https://doi.org/10.18632/oncotarget.25991

Andreas Kleppe,  and Håvard E. Danielsen
32406-32407
PDF  |  Order a Reprint

Research Papers

An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition

An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition

https://doi.org/10.18632/oncotarget.25784

Ayesha T. Chawla, Agnes D. Cororaton, Michael O. Idowu, Priyadarshan K. Damle, Barbara Szomju, Keith C. Ellis, Bhaumik B. Patel,  and Steven R. Grossman
32408-32418
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer

https://doi.org/10.18632/oncotarget.25940

Pushpinder Singh Bawa, Samathmika Ravi, Swagatika Paul, Bibha Chaudhary,  and Subhashini Srinivasan
32419-32434
Abstract  |  PDF  |  HTML  |  Order a Reprint

Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells

Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells

https://doi.org/10.18632/oncotarget.25945

Marjaana Ojalill, Marjaana Parikainen, Pekka Rappu, Elina Aalto, Johanna Jokinen, Noora Virtanen, Elina Siljamäki,  and Jyrki Heino
32435-32447
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling

“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling

https://doi.org/10.18632/oncotarget.25963

Caroline Krogh Søgaard, Augun Blindheim, Lisa M. Røst, Voin Petrović, Anala Nepal, Siri Bachke, Nina-Beate Liabakk, Odrun A. Gederaas, Trond Viset, Carl-Jørgen Arum, Per Bruheim,  and Marit Otterlei
32448-32465
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma

SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma

https://doi.org/10.18632/oncotarget.25977

Damian Mikolaj Janecki, Marcin Sajek, Maciej Jerzy Smialek, Maciej Kotecki, Barbara Ginter-Matuszewska, Bogna Kuczynska, Anna Spik, Tomasz Kolanowski, Riko Kitazawa, Maciej Kurpisz,  and Jadwiga Jaruzelska
32466-32477
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Zac1 regulates IL-11 expression in osteoarthritis

Zac1 regulates IL-11 expression in osteoarthritis

https://doi.org/10.18632/oncotarget.25980

Chun-Lin Kuo, Shu-Ting Liu, Yung-Lung Chang, Chia-Chun Wu,  and Shih-Ming Huang
32478-32495
Abstract  |  PDF  |  HTML  |  Order a Reprint

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells

https://doi.org/10.18632/oncotarget.25985

Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka,  and Kazuma Ohyashiki
32496-32506
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro

https://doi.org/10.18632/oncotarget.25986

Theresa Kordaß, Claudia E.M. Weber, David Eisel, Antonino A. Pane, Wolfram Osen,  and Stefan B. Eichmüller
32507-32522
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases

Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases

https://doi.org/10.18632/oncotarget.25992

Meaghan S. Dendy, Johannes M. Ludwig, Nima Kokabi, Stacey M. Stein, Jill Lacy, Howard S. Hochster,  and Hyun S. Kim
32523-32533
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer

https://doi.org/10.18632/oncotarget.25946

Andrej Jedinak, Kevin R. Loughlin,  and Marsha A. Moses
32534-32550
Abstract  |  PDF  |  HTML  |  Order a Reprint

Retraction

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer

https://doi.org/10.18632/oncotarget.26037

Yu-Ji Li, Ming Dong, Fan-Min Kong, Jian-Ping Zhou, Dong Liang,  and Huan-Zhou Xue
32551-32551
Retraction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC